Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2006-4-4
pubmed:abstractText
Dendritic cell (DC)-based vaccination against cancer is a specific immunotherapy with a new therapeutic approach for patients with cancer. Preclinical and clinical trials, in which more than 1,000 cancer patients received dendritic cell vaccination, have shown that it is possible to activate the immune system against cancer cells and to induce a clinical response in some of the patients. The treatment is so far experimental, and there is a need for well-designed trials that aim to improve the DC vaccine approach.
pubmed:language
dan
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1603-6824
pubmed:author
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1415-20
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Dendrite cell-based cancer vaccines--clinical application].
pubmed:affiliation
Amtssygehuset i Herlev, Onkologisk og Haematologisk Afdeling, og Københavns Universitet, Panum Instituttet, Herlev. inge.m.svane@dadlnet.dk
pubmed:publicationType
Journal Article, English Abstract, Review